Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays

American Journal of Transplantation

Volumn 9, Issue 1, 2009, Pages 83-90

  Blixt, O ^a   Kumagai Braesch, M ^b   Tibell, A ^b   Groth, C G ^b   Holgersson, J ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticarbohydrate antibodies; Blood groups; Glycan arrays; Islet transplantation; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANTIBODY; CARBOHYDRATE ANTIBODY; CARBOHYDRATE BINDING PROTEIN; FORSSMAN ANTIGEN; GALACTOSE; GLYCAN; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; UNCLASSIFIED DRUG;

ACUTE VASCULAR REJECTION; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROARRAY ANALYSIS; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

EID: 58149143098     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02471.x     Document Type: Article

References (47)

1. Auchincloss H, Jr., Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998 16 : 433 470.
2. McKenzie IFC, Koulmanda M, Sandrin MS, Mandel TE. Expression of Galα1,3Gal by porcine islet cells and its relevance to xenotransplantation. Xenotransplantation 1995 2 : 139 142.
3. Rayat GR, Rajotte RV, Elliott JF, Korbutt GS. Expression of Galalpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes 1998 47 : 1406 1411.
4. Bennet W, Bjorkland A, Sundberg B et al. A comparison of fetal and adult porcine islets with regard to Gal alpha (1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity. Transplantation 2000 69 : 1711 1717.
5. Strokan V, Bennet W, Molne J, Korsgren O, Breimer ME. Distribution of the Galalpha1-3Gal antigen in cultured adult and fetal porcine pancreatic islet cells: An immunoelectron microscopic study. Transplantation 2000 70 : 846 851.
6. McKenzie IF, Koulmanda M, Mandel TE, Sandrin MS. Pig islet xenografts are susceptible to "anti-pig" but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice. J Immunol 1998 161 : 5116 5119.
7. Kuwaki K, Tseng Y-L, Dor FJMF et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005 11 : 29 31.
8. Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005 11 : 1295 1298.
9. Milland J, Christiansen D, Lazarus BD, Taylor SG, Xing PX, Sandrin MS. The molecular basis for Galα(1,3)Gal expression in animals with a deletion of the α1,3galactosyltransferase gene. J Immunol 2006 176 : 2448 2454.
10. Sharma A, Naziruddin B, Cui C et al. Pig cells that lack the gene for α1-3 galactosyltransferase express low levels of the Gal antigen. Transplantation 2003 75 : 430 436.
11. Diswall M, Ångström J, Schuurman H-J, Dor FJMF, Rydberg L, Breimer ME. Studies on glycolipid antigens in small intestine and pancreas from α1,3-galactosyltransferase knockout miniature swine. Transplantation 2007 84 : 1348 1356.
12. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002 9 : 376 381.
13. Miwa Y, Kobayashi T, Nagasaka T et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004 11 : 247 253.
14. Holgersson J, Cairns TDH, Karlsson EC et al. Carbohydrate specificity of human immunoglobulin-M antibodies with pig lymphocytotoxic activity. Transplant Proc 1992 24 : 605 608.
15. Cairns T, Lee J, Goldberg LC et al. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation. Transplant Proc 1996 28 : 795 796.
16. Rydberg L, Cairns TDH, Groth CG et al. Specificities of human IgM and IgG anticarbohydrate xenoantibodies found in the sera of diabetic patients grafted with fetal pig islets. Xenotransplantation 1994 1 : 69 79.
17. Obukhova P, Rieben R, Bovin N. Normal human serum contains high levels of anti-Galα1-4GlcNAc antibodies. Xenotransplantation 2007 14 : 627 635.
18. Bouhours D, Liaigre J, Richard C, Oriol R, Bouhours JF. Forssman penta- and tetraglycosylceramide are xenoantigens of ostrich kidney and liver. Glycobiology 1999 9 : 875 886.
19. Bäcker AE, Holgersson J, Samuelsson BE, Karlsson H. Rapid and sensitive GC/MS characterization of glycolipid released Galalpha1,3Gal- terminated oligosaccharides from small organ specimens of a single pig. Glycobiology 1998 8 : 533 545.
20. Holgersson J, Jovall PA, Samuelsson BE, Breimer ME. Structural characterization of non-acid glycosphingolipids in kidneys of single blood group O and A pigs. J Biochem 1990 108 : 766 777.
21. Bouhours D, Liaigre J, Naulet J, Bovin NV, Bouhours JF. A novel pentaglycosylceramide in ostrich liver, IV4-beta-Gal-nLc4Cer, with terminal Gal(beta1-4)Gal, a xenoepitope recognized by human natural antibodies. Glycobiology 2000 10 : 857 864.
22. Lucq J, Tixier D, Guinault AM, Greffard A, Loisance D, Pilatte Y. The target antigens of naturally occurring human anti-β-galactose IgG are cryptic on porcine aortic endothelial cells. Xenotransplantation 2000 7 : 3 13.
23. Groth CG, Korsgren O, Tibell A et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994 344 : 1402 1404.
24. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995 59 : 1549 1556.
25. Satake M, Kumagai-Braesch M, Kawagishi N, Tibell A, Groth CG, Möller E. Kinetics and character of xenoantibody formation in diabetic patients transplanted with fetal porcine islet cell clusters. Xenotransplantation 1994 1 : 24.
26. Lindeborg E, Kumagai-Braesch M, Tibell A, Moller E. Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation 2001 8 : 273 283.
27. Blixt O, Head S, Mondala T et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 2004 101 : 17033 17038.
28. Holgersson J, Löfling J. Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity. Glycobiology 2006 16 : 584 593.
29. Löfling J, Diswall M, Eriksson S, Borén T, Breimer ME, Holgersson J. Studies of Lewis antigens and H. pylori adhesion in CHO cell lines engineered to express Lewis b determinants. Glycobiology 2008 18 : 494 501.
30. Löfling J, Holgersson J. Core saccharide dependence of Sialyl Lewis X biosynthesis. Glycoconj J 2008 Jul 8 [Epub ahead of print].
31. Satake M, Kawagishi N, Rydberg L et al. Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters. Main antibody reactivity against α-galactose containing epitopes. Xenotransplantation 1994 1 : 89 101.
32. Bouhours D, Liaigre J, Naulet J, Maume D, Bouhours J. A novel glycosphingolipid expressed in pig kidney: Gal alpha 1-3Lewis(x) hexaglycosylceramide. Glycoconj J 1997 14 : 29 38.
33. McKane W, Lee J, Preston R et al. Polymorphism in the human anti-pig natural antibody repertoire. Implications for antigen-specific immunoadsorption. Transplantation 1998 66 : 626 633.
34. Higashi H, Naiki M, Matsuo S, Okouchi K. Antigen of 'serum sickness' type of heterophile antibodies in human sera: Identification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 1977 79 : 388 395.
35. Merrick JM, Schifferle R, Zadarlik K, Kano K, Milgrom F. Isolation and partial characterization of the heterophile antigen of infectious mononucleosis from bovine erythrocytes. J Supramol Struct 1977 6 : 275 290.
36. Merrick JM, Zadarlik K, Milgrom F. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolylneuraminic acid. Int Arch Allergy Appl Immunol 1978 57 : 477 480.
37. Bouhours D, Pourcel C, Bouhours JF. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal alpha 1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj J 1996 13 : 947 953.
38. Saethre M, Baumann BC, Fung M, Seebach JD, Mollnes TE. Characterization of natural human anti-non-Gal antibodies and their effect on activation of porcine Gal-deficient endothelial cells. Transplantation 2007 84 : 244 250.
39. Kobayashi T, Yokoyama I, Suzuki A et al. Lack of antibody production against Hanganutziu-Deicher (H-D) antigens with N-glycolylneuraminic acid in patients with porcine exposure history. Xenotransplantation 2000 7 : 177 180.
40. Apoil P-A, Roubinet F, Despiau S, Mollicone R, Oriol R, Blancher A. Evolution of α2-fucosyltransferase genes in primates: Relation between an intronic Alu-Y element and red cell expression of ABH antigens. Mol Biol Evol 2000 17 : 337 351.
41. Kawa S, Tokoo M, Oguchi H et al. Epitope analysis of SPan-1 and DUPAN-2 using synthesized glycoconjugates Sialyllact-N-Fucopentaose II and Sialyllact-N-Tetraose. Pancreas 1994 9 : 692 697.
42. Lan MS, Khorrami A, Kaufman B, Metzgar RS. Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. J Biol Chem 1987 262 : 12863 12870.
43. Borowitz MJ, Tuck FL, Sindelar WF, Fernsten PD, Metzgar RS. Monoclonal antibodies against human pancreatic adenocarcinoma: Distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst 1984 72 : 999 1005.
44. Metzgar RS, Gaillard MT, Levine SJ, Tuck FL, Bossen EH, Borowitz MJ. Antigens of human pancreatic adenocarcinoma cells defined by murine monclonal antibodies. Cancer Res 1982 42 : 601 608.
45. Metzgar RS, Rodriguez N, Finn OJ et al. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 1984 81 : 5242 5246.
46. Holgersson J, Gustafsson A, Breimer ME. Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies. Immunol Cell Biol 2005 83 : 694 708.
47. Milland J, Yuriev E, Xing PX, McKenzie IFC, Ramsland PA, Sandrin MS. Carbohydrate residues downstream of the terminal Galα(1,3)Gal epitope modulate the specificity of xenoreactive antibodies. Immunol Cell Biol 2007 85 : 623 632.